Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
XBIO | US
-0.05
-1.44%
Healthcare
Biotechnology
30/06/2024
21/10/2024
3.77
3.78
3.81
3.67
Xenetic Biosciences Inc. a biopharmaceutical company focuses on advancing XCART a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the development of biologic drugs and therapeutics. It advances cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. In addition the company leveraging PolyXen its proprietary drug delivery platform by partnering with biotechnology and pharmaceutical companies. It has collaboration agreements with Takeda Pharmaceutical Co. Ltd. Serum Institute of India Limited and PJSC Pharmsynthez. Xenetic Biosciences Inc. is headquartered in Framingham Massachusetts.
View LessValue Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
45.8%1 month
73.6%3 months
81.3%6 months
78.2%-
-
0.79
-
-
1.03
0.12
-
-5.75M
5.81M
5.81M
-
-184.11
-
11.60
-48.61
0.20
0.21
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.87
Range1M
1.53
Range3M
2.40
Rel. volume
0.20
Price X volume
14.30K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Oncternal Therapeutics Inc | ONCT | Biotechnology | 2.09 | 6.19M | 45.64% | n/a | 1.49% |
Portage Biotech Inc | PRTG | Biotechnology | 5.83 | 6.11M | -4.89% | 0.25 | 1.47% |
Hoth Therapeutics Inc | HOTH | Biotechnology | 0.88 | 6.08M | -5.22% | n/a | 0.44% |
PALISADE BIO INC | PALI | Biotechnology | 3.91 | 5.41M | 0.51% | n/a | 5.06% |
ERNA | ERNA | Biotechnology | 0.9899 | 5.36M | -2.95% | n/a | -577.12% |
XORTX Therapeutics Inc. Common Stock | XRTX | Biotechnology | 1.71 | 5.15M | -9.04% | n/a | 3.09% |
BIONOMICS LIMITED/FI | BNOX | Biotechnology | 0.2955 | 5.12M | -1.53% | n/a | 0.59% |
180 Life Sciences Corp | ATNF | Biotechnology | 4.97 | 5.10M | -1.19% | n/a | -105.81% |
Molecular Templates Inc | MTEM | Biotechnology | 0.75 | 4.94M | 0.00% | n/a | 155.07% |
QLGN | QLGN | Biotechnology | 0.1825 | 4.93M | 9.15% | n/a | -39.04% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.4659 | 4.44M | -2.96% | n/a | 19.98% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.19 | 2.99M | -13.68% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.06 | 2.71M | 0.00% | n/a | 17.32% |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 3.65 | 2.01M | -6.89% | n/a | 0.00% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.011 | 1.01M | 10.00% | n/a | -37.05% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 1.03 | 0.53 | Expensive |
Ent. to Revenue | 0.12 | 3,967.00 | Cheaper |
PE Ratio | - | 41.03 | - |
Price to Book | 0.79 | 15.55 | Cheaper |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 81.27 | 72.80 | Par |
Debt to Equity | - | -1.23 | - |
Debt to Assets | - | 0.25 | - |
Market Cap | 5.81M | 3.66B | Emerging |